Safe Reduction of Antibiotic Therapy in Newborn Infants Using Interleukin 8 (IL-8) and C-Reactive Protein (CRP) as Markers of Nosocomial Bacterial Infections (NBI) | Zendy

AI Assistant Blog Pricing

Safe Reduction of Antibiotic Therapy in Newborn Infants Using Interleukin 8 (IL-8) and C-Reactive Protein (CRP) as Markers of Nosocomial Bacterial Infections (NBI)

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.